Holen Sie sich die Stockscreener-App
11.43
4.67%
-0.56
Handel nachbörslich:
11.58
0.15
+1.31%
Ernexa Therapeutics Inc Aktie (ERNA) Neueste Nachrichten
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models - BioInformant
Ernexa Therapeutics Inc. (ERNA) Q3 2023 Earnings: Narrowing Losses Amidst Pipeline ProgressRevenue Report - Newser
Ernexa Therapeutics (ERNA) Q3 2023 Earnings: Deepening Losses and Clinical-Phase Uncertainty Weigh on SharesPro Level Trade Signals - Newser
Ernexa Therapeutics Q3 2023 Earnings: Losses Deepen as Stock Declines, No Revenue ReportedGuidance Revision Trend - Newser
Ernexa Therapeutics (ERNA) Slips 3.8% as Shares Test Key Support Near $11.39Sentiment Extreme - Newser
ERNA stock shoots up 140% in a month: Here's what you should know - MSN
Clear Street exits ownership reporting for Ernexa Therapeutics (NASDAQ: ERNA) - Stock Titan
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know - sharewise.com
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity - The Globe and Mail
Ernexa Therapeutics stock climbs on breakthrough preclinical data - MSN
ernexa therapeutics inc. Earnings dates - RTTNews
Ernexa Therapeutics (ERNA): Trustees report 66,751 shares, 5.6% stake - Stock Titan
ERNA stock almost doubled in value today – smashing rally leads to 7 trading halts - MSN
Ernexa Therapeutics Inc (ERNA) Stock Price, Quote, News & History - Benzinga
Ernexa Therapeutics (ERNA) 10K Form and Latest SEC Filings 2026 - MarketBeat
ERNA | Ernexa Therapeutics Inc. Common Analyst Forecasts - Quiver Quantitative
Bleichroeder LP discloses 6.86% stake in Ernexa Therapeutics (ERNA) - Stock Titan
Clear Street LLC reports 12.8% stake in Ernexa (NASDAQ: ERNA) - Stock Titan
Ernexa Therapeutics (ERNA) amendment: 118,342 shared holdings; 48,000 warrants noted - Stock Titan
Ernexa Stock Is Jumping Today: What's Going On? - Sahm
Nasdaq Dips Over 1%; US Inflation Surges To 3.8% In April - Sahm
Ernexa Therapeutics (ERNA) Stock Soars 78% Following Q1 Earnings and Pipeline Update - MEXC
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes - TechStock²
Ernexa Therapeutics (ERNA) Stock Jumps Over 78% as Q1 Loss Narrows - MEXC
Ernexa Therapeutics (ERNA) Stock Soars 78% Following Improved Q1 Financials - parameter.io
Ernexa Therapeutics (ERNA) Stock Soars 78% Following Improved Q1 Earnings Report - MoneyCheck
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
ERNA Stock Almost Doubled In Value Today – Smashing Rally Leads To 7 Trading Halts - Stocktwits
[ARS] Ernexa Therapeutics Inc. SEC Filing - Stock Titan
Ernexa Therapeutics (NASDAQ: ERNA) details 2026 meeting, equity plan and insider ownership - Stock Titan
Ernexa Therapeutics Inc. 1Q 2026: Net loss $(5.51)M, EPS $(6.95) — 10-Q Summary - TradingView
Ernexa Therapeutics (ERNA) trims Q1 2026 loss, boosts cash with $10.5M offering - Stock Titan
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101 - Weekly Voice
Ernexa Therapeutics Releases Virtual Investor KOL Connect - GlobeNewswire
ERNA shares fall 3.71% as Ernexa Therapeutics posts Q3 loss of $1.03 per share.Shared Trade Alerts - Newser
Ernexa Therapeutics Inc.: Target Price Consensus and Analysts Recommendations | ERNA | US1140824079 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
ERNA Stock Skyrockets After ERNA-101 Delivers Tumor Clearance - timothysykes.com
Top Small Cap Stocks To Add to Your WatchlistMay 6th - MarketBeat
Why Ernexa Therapeutics Stock Jumped After ERNA-101 Ovarian Cancer Survival Data - TechStock²
What separates Ernexa Therapeutics (ERNA) from the pack? (Smart Money Flows) 2026-05-06Bollinger Bands - Newser
ERNA Stock Surged 60% Today – Here’s Why Retail Is Buzzing About Ernexa’s Ovarian Cancer Trial Results - Stocktwits
Ernexa Therapeutics Stock Climbs On Breakthrough Preclinical Data - Benzinga
Ernexa Therapeutics (ERNA) Preclinical Data Shows 100% Survival and Complete Tumor Clearance in Ovarian Cancer Models - Yahoo Finance
ERNA Stock Explodes Higher As Tiny Biotech Draws Trader Focus - StocksToTrade
ERNA Stock Rockets Higher As Traders Target Breakout Move - timothysykes.com
Ernexa reports preclinical data for ovarian cancer therapy - Investing.com
Ernexa reports preclinical data for ovarian cancer therapy By Investing.com - Investing.com Canada
Ernexa stock surges 40% on ovarian cancer trial results By Investing.com - Investing.com Canada
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):